| 94 |
Efficacy and safety of tenofovir alafenamide versus tenofovir disoproxil fumarate in treatment-naïve chronic hepatitis B
|
2022-10-06 |
1244 |
| 93 |
Impact of expanding hepatitis B treatment guidelines: A modelling and economic impact analysis
|
2022-10-06 |
1274 |
| 92 |
Increasing on-treatment hepatocellular carcinoma risk with decreasing baseline viral load in HBeAg-positive chronic hepatitis B
|
2022-10-06 |
1311 |
| 91 |
Toxicity of Proton Therapy versus Photon Therapy on Salvage Re-Irradiation for Non-Small Cell Lung Cancer
|
2022-09-28 |
1241 |
| 90 |
Prospective Study of Proton Therapy for Lung Cancer Patients with Poor Lung Function or Pulmonary Fibrosis
|
2022-09-28 |
1294 |
| 89 |
Specialist Perception of Severe Asthma in Korea: A Questionnaire Survey
|
2022-09-28 |
1221 |
| 88 |
Interstitial lung disease increases susceptibility to and severity of COVID-19
|
2022-09-28 |
1259 |
| 87 |
Short-Acting Beta2-Agonist Use in Asthma in Korea: A 10-Year Population-Based Study
|
2022-09-26 |
1304 |
| 86 |
Predicting Factors of Severe COVID-19 in Patients With Asthma: A Korean National Cohort Study
|
2022-09-26 |
1212 |
| 85 |
The Korean Severe Asthma Registry (KoSAR): real world research in severe asthma
|
2022-09-26 |
1191 |
